The Beyond Study
Un estudio sobre el consumo de alcohol y marihuana en jóvenes universitarios de La Paz, Bolivia
BEYOND es un estudio de investigación de la University of Central Florida (UCF) en colaboración con la Universidad Mayor de San Andrés, la Universidad Privada del Valle y la Universidad Católica Boliviana. Buscamos entender cómo y por qué los jóvenes adultos consumen alcohol y marihuana al mismo tiempo, y qué factores personales, familiares y sociales influyen en ese consumo.
Es el primer estudio de este tipo en Bolivia. Lo que aprendamos servirá para diseñar programas de prevención adaptados a la realidad y la cultura de los jóvenes bolivianos.
Consulta el flyer para conocer los requisitos de participación y cómo inscribirte.
Click para el Flyer
The WAVE Study
Evaluating the Efficacy of Water-Soluble CBD in Reducing Risky Alcohol Use: A Randomized Controlled Trial
The study has not yet received IRB approval and participant recruitment is not currently open.
The WAVE Study is a double-blind, randomized, placebo-controlled pilot trial testing whether water-soluble cannabidiol (CBD) can help adults who drink at risky levels cut back. Participants will be randomly assigned to one of three groups: full-spectrum water-soluble CBD, broad-spectrum water-soluble CBD, or placebo. Water-soluble formulations are designed to improve how CBD is absorbed, which may make it more practical as a treatment. Findings from WAVE will inform a larger trial of cannabinoid-based approaches to alcohol use disorder. WAVE is supported by the Consortium for Medical Marijuana Clinical Outcomes Research.
CannaBev Study: Understanding THC-Infused Beverage Use Among Young Adults a Cross-sectional Study
THC-infused beverages, such as seltzers, sodas, teas, and cocktail-style drinks, are growing in popularity. This national study examines how U.S. adults ages 18–34 use these products and what they understand about THC content, dosage, effects, and potential risks.
Findings will help inform consumer education, public-health messaging, and product-labeling guidance.
Follow us on all social media platforms to keep updated
Partnership with Tikun Olam
We are currently in discussions with Tikun Olam about a potential collaboration to develop a prospective patient registry evaluating the real-world safety, effectiveness, and patient experience of its standardized medical cannabis products. The proposed registry would follow patients over time to assess symptom outcomes, quality of life, treatment patterns, and safety in routine clinical care.
Follow us on all social media platforms to keep updated